1. 내용 Key Highlights When cancer drugs fail, a unique combination of already existing drugs could harness an under-targeted part of the immune system to join the fight A new study led by Penn State College of Medicine scientists finds that another type of immune cell — natural killer cells — can be harnessed to pick up the slack when T cells no longer work and may also reinvigorate T cells to at..